The NR2B subunit-selective NMDA receptor antagonist, CP-101,606 reduces pain intensity in patients with central and peripheral neuropathic pain
Sang CN, Weaver JJ, Jinga L, Wouden J, Saltarelli MD. The NR2B subunit-selective NMDA receptor antagonist, CP-101,606 reduces pain intensity in patients with central and peripheral neuropathic pain. Society for Neuroscience. 2003.